Table 2.
Primary diagnosis at the time of initial referral and associated fundus findings at presentation.
| Findings | Value |
|---|---|
| Primary diagnosis | |
| Choroidal melanoma | 20/43 (55.6) |
| Vitreous hemorrhage/opacity | 7/43 (25.0) |
| Retinal detachment | 3/43 (8.3) |
| PEHCR | 3/43 (8.3) |
| Age-related macular degeneration | 2/43 (5.6) |
| Metastatic cancer | 2/43 (5.6) |
| Hemangioma | 1/43 (2.8) |
| Location of PEHCR lesions | |
| Inferotemporal | 25/43 (58.1) |
| Superotemporal | 22/43 (51.2) |
| Inferonasal | 3/43 (6.9) |
| Superonasal | 2/43 (4.7) |
| Peripheral findings | |
| Exudation | 28/43 (65.1) |
| Subretinal and subretinal pigment epithelium hemorrhage | 23/43 (53.5) |
| Vitreous hemorrhage | 18/43 (41.9) |
| Subretinal fluid | 11/43 (25.6) |
| Chorioretinal atrophy | 2/43 (4.7) |
| Retinal fibrosis | 1/43 (2.3) |
| Macular OCT findings | |
| Drusen | 13/43 (30.2) |
| Subretinal hemorrhage | 6/43 (14.0) |
| Macular atrophy | 2/43 (4.7) |
| Retinal detachment | 2/43 (4.7) |
| Epiretinal membrane | 1/43 (2.3) |
| FA/ICGA findings | 32/43 (74.4) |
| Blocked fluorescence | 18/32 (56.2) |
| Peripheral leakage | 17/32 (53.1) |
| Peripheral polypoidal lesions | 5/32 (15.6) |
| Macular neovascularization | 2/32 (6.3) |
Values were presented as the number of specific variables/total number of eyes (%).
FA, fluorescein angiography; ICGA, indocyanine green angiography; OCT, optical coherence tomography; PEHCR, peripheral exudative hemorrhagic chorioretinopathy.